1. Home
  2. SVV vs CAPR Comparison

SVV vs CAPR Comparison

Compare SVV & CAPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Savers Value Village Inc.

SVV

Savers Value Village Inc.

N/A

Current Price

$8.49

Market Cap

1.4B

ML Signal

N/A

Logo Capricor Therapeutics Inc.

CAPR

Capricor Therapeutics Inc.

N/A

Current Price

$30.71

Market Cap

1.3B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
SVV
CAPR
Founded
1954
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Other Specialty Stores
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
1.3B
IPO Year
2021
2011

Fundamental Metrics

Financial Performance
Metric
SVV
CAPR
Price
$8.49
$30.71
Analyst Decision
Buy
Strong Buy
Analyst Count
7
8
Target Price
$13.67
$41.38
AVG Volume (30 Days)
1.1M
921.3K
Earning Date
05-08-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.14
N/A
Revenue
$1,678,954,000.00
$22,270,465.00
Revenue This Year
$6.91
N/A
Revenue Next Year
$7.58
$17,308.50
P/E Ratio
$62.32
N/A
Revenue Growth
9.19
N/A
52 Week Low
$6.48
$4.30
52 Week High
$13.89
$40.37

Technical Indicators

Market Signals
Indicator
SVV
CAPR
Relative Strength Index (RSI) 27.73 66.95
Support Level $7.69 $22.09
Resistance Level $11.21 $40.37
Average True Range (ATR) 0.56 1.84
MACD -0.18 0.17
Stochastic Oscillator 10.46 92.68

Price Performance

Historical Comparison
SVV
CAPR

About SVV Savers Value Village Inc.

Savers Value Village Inc is a for-profit thrift operator in the United States and Canada. It purchases second-hand textiles (i.e., clothing, bedding, and bath items), shoes, accessories, housewares, books, and other goods from its non-profit partners (NPPs), either directly from them or via on-site donations (OSDs) at Community Donation Centers at its stores. The company then processes, selects, prices, and sells these items in its stores.

About CAPR Capricor Therapeutics Inc.

Capricor Therapeutics Inc is a clinical-stage biotechnology company focused on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (DMD), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with high unmet medical needs. The company's product pipeline includes CAP-1002, deramiocel an allogeneic cardiac-derived cell therapy. Deramiocel is currently advancing through Phase 3 clinical development for the treatment of Duchenne muscular dystrophy. Through its proprietary StealthXTM platform, the group uses its exosome technology to conduct preclinical research focused on vaccinology, delivering oligonucleotides, proteins, and small molecules to treat.

Share on Social Networks: